Michael Petusky

Stock Analyst at Barrington Research

(2.03)
# 2,732
Out of 4,814 analysts
188
Total ratings
33.94%
Success rate
-8.55%
Average return

Stocks Rated by Michael Petusky

Merit Medical Systems
Apr 11, 2025
Maintains: Outperform
Price Target: $111
Current: $90.82
Upside: +22.23%
Anika Therapeutics
Mar 13, 2025
Maintains: Outperform
Price Target: $25$20
Current: $13.98
Upside: +43.11%
OPKO Health
Mar 12, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.43
Upside: +57.89%
VerifyMe
Mar 7, 2025
Maintains: Outperform
Price Target: $1.5$1.25
Current: $0.63
Upside: +98.26%
ModivCare
Mar 7, 2025
Maintains: Outperform
Price Target: $10$6
Current: $0.96
Upside: +523.25%
DENTSPLY SIRONA
Feb 28, 2025
Maintains: Outperform
Price Target: $24$20
Current: $12.84
Upside: +55.76%
U.S. Physical Therapy
Feb 28, 2025
Maintains: Outperform
Price Target: $108$98
Current: $67.28
Upside: +45.66%
LeMaitre Vascular
Feb 28, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $86.28
Upside: -
Option Care Health
Feb 27, 2025
Maintains: Outperform
Price Target: $33$38
Current: $32.26
Upside: +17.79%
Henry Schein
Feb 26, 2025
Maintains: Outperform
Price Target: $90
Current: $64.28
Upside: +40.01%
Maintains: Outperform
Price Target: $108$95
Current: $58.23
Upside: +63.16%
Downgrades: Market Perform
Price Target: n/a
Current: $6.42
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $27.67
Upside: -